临床试验/CTRI/2025/10/095821

CTRI/2025/10/095821尚未招募不适用

The Clinical Utility Of Boger Boenninghausens Characteristics and Repertory in the Management of Irritable Bowel Syndrome

Department of Homoeopathic Repertory and Case Taking,White Memorial Homoeopathy Medical College1 个研究点分布在 1 个国家目标入组 30 人开始时间: 2025年12月5日最近更新: 2025年9月29日

试验速览

阶段: 不适用
状态: 尚未招募
发起方
入组人数: 30
试验地点: 1
主要终点: • MARKED IMPROVEMENT: More than 75% score

研究概览研究设计入排标准结局指标研究者研究点记录与标识符相似试验

研究概览

简要总结

To assess the relief symptoms in irritable bowel syndrome and their changes in level score after homoeopathic treatment using Boger Boenninghausen’s characteristics and repertory with individualised homoeopathy medicine with two weeks once follow up .

研究设计

研究类型: Interventional
分配方式: Na
盲法: None

入排标准

年龄范围: 35.00 Year(s) 至 50.00 Year(s)（—）
性别: All

入选标准

•Age group from 35 to 50 years.
•Sex: Male & Female All cases that fit into ROME 1V diagnostic criteria.

排除标准

•Cases that do not satisfy the ROME IV criteria.
•Patient who are already under treatment for Gastrointestinal disorders.
•Pregnant and lactation women.
•Patients suffering from other systemic illness who are under medication.

结局指标

主要结局

• MARKED IMPROVEMENT: More than 75% score

时间窗: 6 months

• MODERATE IMPROVEMENT: 40-75%

时间窗: 6 months

Assessment of Improvement will be done by IBS-SSS Before and after treatment.Outcome will be classified as follows:

时间窗: 6 months

• MILD IMPROVEMENT: 5-40%

时间窗: 6 months

• NO IMPROVEMENT:Less than 5%

时间窗: 6 months

次要结局

TO understanding The utility of Boger Boenninghusens Characteristics and Repertory.(6 months)

研究者

发起方

Department of Homoeopathic Repertory and Case Taking,White Memorial Homoeopathy Medical College

申办方类型

Private medical college

责任方

Principal Investigator

主要研究者

Dr Ancin A N

White Memorial Homoeopathy Medical College, Attoor

研究点 (1)

Loading locations...

相似试验

已完成

不适用

(FODMAP) Diet on Improving Symptoms of Patients With Irritable Bowel Syndrome

NCT07299305Zagazig University183

尚未招募

2/3 期

Role of Lavangadi churna in Grahani or Irritable bowel syndrome.

CTRI/2025/12/099029Dr Manoj S Ambrad30

尚未招募

不适用

To study the utility of homoeopathic medicines in the treatment of Irritable Bowel Syndrome among adults

CTRI/2025/11/096989Dr Sanjeevani Patiil37

招募中

2/3 期

Effects of Bacillus Clausii with IBS-Diarrhea patients

CTRI/2025/07/090307S K Biobiz Pvt Ltd46

尚未招募

4 期

Use of KENT Homoeopathic Repertory in treatment of Irritable Bowel Syndrome

CTRI/2025/06/089711RBTS Government Homoeopathic Medical College and Hospital40